MERCK plans to build a new campus in Burlington, Mass., which will serve as a major hub for its North American life science business. The 280,000-square-foot facility will include a customer collaboration laboratory and training center, as well as office space. “This new and more expansive Merck campus gives us a unique, multi-use life science... […]
NIH will work with Wondros, a Los Angeles-based creative communications and design agency, to design and implement the communications strategy for the Precision Medicine Initiative Cohort Program. Wondros is working with other academic institutions, private sector and federal agencies to implement communications strategies that appeal to different populations, ensuring that the PMI has a broad... […]
GlaxoSmithKline and the University of Leicester in the U.K. will collaborate to discover and develop novel medicines to treat high-grade non-Hodgkin’s lymphoma. The project is part of GSK’s Discovery Partnerships with Academia initiative. Professor Simon Wagner, from the Department of Cancer Studies, who is leading the project on behalf of the University of Leicester, said:... […]
VY DINH and MARIANA KHAWAND-AZOULAI joined Miami Cancer Institute at Baptist Health South Florida. Dinh is a hospital oncologist, and Khawand-Azoulai will provide outpatient palliative care, including pain and symptom management and psychosocial support. Most recently, Dinh served as a staff physician for hematology, oncology and medicine at the Miami VA Medical Center, as well... […]
Kisplyx (lenvatinib), in combination with everolimus, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use for the treatment of adult patients with advanced renal cell carcinoma following one prior vascular endothelial growth factor targeted therapy. The opinion was based on results from a phase II trial that showed... […]
RAJESWARI NAGARATHINAM joined the department of pathology at Fox Chase Cancer Center, focusing on both surgical pathology and cytopathology. After earning her medical degree at Coimbatore Medical College in India, Nagarathinam completed residency training in pathology at Madras Medical College, also in India. She completed a residency in pathology at the University of Oklahoma Health... […]
Health Canada approved Imbruvica (ibrutinib) as an oral, once-daily, single-agent targeted therapy for previously untreated patients with active chronic lymphocytic leukemia. This is the fourth Canadian approval for Imbruvica, which is now approved for use in all lines of CLL therapy.
ABHISHEK APHALE was appointed assistant professor of dermatology at Fox Chase Cancer Center. Aphale specializes in Mohs surgery and reconstruction and cutaneous oncology. His research interests include squamous cell carcinoma, basal cell carcinoma, melanoma and rare cutaneous tumors. Aphale earned his medical degree from the Robert Wood Johnson Medical School in New Brunswick, N.J. He... […]
CHARLES SIMONE II was named medical director of the Maryland Proton Treatment Center, effective in November. Simone will help define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System and the university’s school of medicine. He will... […]
SUSAN PITT received a Young Investigator Award from UW Carbone Cancer Center. Pitt is an assistant professor of surgery who specializes in endocrine surgery and thyroid cancer. She joined the cancer center in August 2015. Pitt will use the award to study why providers often overtreat thyroid microcancers, those that measure one centimeter or less... […]
